ICU

SeaStar Medical Holding Corporation · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website eastarmedical.com
Employees(FY) 9
ISIN US81256L1044

Performance

-10.35%

1W

-45.61%

1M

-66.7%

3M

-35.57%

6M

-12.74%

YTD

-34.53%

1Y

Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.

Advanced Technical Analysis

Technical Analysis of ICU 2024-05-10

Overview:

In analyzing the technical indicators for ICU stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potentia...

See more ...

Recent News & Updates

2024-05-14 04:05
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update(Globenewswire)
2024-04-29 20:30
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure(Globenewswire)
2024-04-17 04:00
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update(Globenewswire)
2024-04-16 11:52
ICU Stock Earnings: SeaStar Medical Holding Misses EPS for Q4 2023(Investorplace)
2024-04-10 20:30
SeaStar Medical to Present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference(Globenewswire)
2024-04-01 23:26
LM Funding America, Inc. (NASDAQ:LMFA) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-26 20:30
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17(Globenewswire)
2024-03-11 20:30
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients(Globenewswire)
2024-03-11 04:05
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024(Globenewswire)
2024-02-26 19:30
Manuscript Discussing the Benefit of SeaStar Medical's Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure(Globenewswire)
2024-02-21 18:58
Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune(Globenewswire)
2024-02-21 18:53
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical's Selective Cytopheretic Device for Pediatric Acute Kidney Injury(Globenewswire)
2024-01-31 19:30
SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology(Globenewswire)
2024-01-25 19:05
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market(Globenewswire)
2024-01-11 03:05
SeaStar Medical Appoints David A. Green as Chief Financial Officer(Globenewswire)
2024-01-08 19:30
SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications(Globenewswire)
2023-12-27 19:30
SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury(Globenewswire)
2023-12-12 19:30
SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts(Globenewswire)
2023-11-14 03:04
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update(Globenewswire)
2023-10-30 20:00
Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device(Globenewswire)
2023-10-30 09:00
Discover the Next Nokia: 3 Penny Stocks With Big Potential(Yahoo Finance)
2023-10-29 20:00
FDA Issues Approvable Letter for SeaStar Medical's Selective Cytopheretic Device for Pediatric Patients(Globenewswire)
2023-10-17 20:30
FDA Grants SeaStar Medical's Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome(Globenewswire)
2023-10-04 20:30
SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023(Globenewswire)
2023-10-03 04:05
SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption(Globenewswire)
2023-10-02 07:08
3 Micro-Cap Stocks Set to Explode Higher(Yahoo Finance)
2023-09-28 20:30
FDA Grants Breakthrough Device Designation to SeaStar Medical's Selective Cytopheretic Device for Cardiorenal Syndrome(Globenewswire)
2023-09-20 21:35
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference(Yahoo Finance)
2023-08-28 20:00
Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medicals Selective Cytopheretic Device Published in the Journal Blood Purification(Yahoo Finance)
2023-08-21 20:00
SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time(Yahoo Finance)

Page 1 of 2

previousnext